Literature DB >> 3498086

[Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin].

U König, U Müller, U Binswanger.   

Abstract

Three initial treatment schedules of peritonitis during continuous ambulatory peritoneal dialysis are analysed. In 20 patients 56 episodes of peritonitis were treated by co-trimoxazole, 29 episodes in 20 patients by cefazolin, and 29 infections in 22 patients by vancomycin. The efficiency of the treatment modes was comparable. Vancomycin was found to be appropriate in particular because of the resistance characteristics of bacterial isolates.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498086     DOI: 10.1007/BF01727623

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Peritoneal transport of vancomycin during peritoneal dialysis.

Authors:  H E Nielsen; I Sørensen; H E Hansen
Journal:  Nephron       Date:  1979       Impact factor: 2.847

2.  Peritonitis during continuous ambulatory peritoneal dialysis: improving patient defense by type of buffer of dialysate?

Authors:  U Binswanger; G Keusch; F Bammatter; H Heule; D Kiss
Journal:  Nephron       Date:  1981       Impact factor: 2.847

3.  Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies.

Authors:  R Gokal; J M Ramos; D M Francis; R E Ferner; T H Goodship; G Proud; A J Bint; M K Ward; D N Kerr
Journal:  Lancet       Date:  1982-12-18       Impact factor: 79.321

4.  Centrifugation of 50 ml of peritoneal fluid is sufficient for microbiological examination in continuous ambulatory peritoneal dialysis (CAPD) patients with peritonitis.

Authors:  H Hächler; K Vogt; U Binswanger; A von Graevenitz
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

5.  Intravenous vancomycin as initial treatment for gram-positive peritonitis in patients on chronic peritoneal dialysis.

Authors:  L E Obermiller; A H Tzamaloukas; P Leymon; P S Avasthi
Journal:  Clin Nephrol       Date:  1985-11       Impact factor: 0.975

6.  Serum and dialyzate concentrations of intraperitoneal cephalothin in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  R Münch; J Steurer; R Lüthy; W Siegenthaler; U Kuhlmann
Journal:  Clin Nephrol       Date:  1983-07       Impact factor: 0.975

7.  Treatment of peritonitis in continuous ambulatory peritoneal dialysis patients with co-trimoxazole.

Authors:  P Glasson; H Favre
Journal:  Nephron       Date:  1984       Impact factor: 2.847

8.  Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis.

Authors:  J C Ayus; J F Eneas; T G Tong; N L Benowitz; P Y Schoenfeld; K L Hadley; C E Becker; M H Humphreys
Journal:  Clin Nephrol       Date:  1979-03       Impact factor: 0.975

9.  Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.

Authors:  C E Halstenson; R B Blevins; N G Salem; G R Matzke
Journal:  Clin Nephrol       Date:  1984-11       Impact factor: 0.975

10.  Vancomycin and netilmicin as first line treatment of peritonitis in CAPD patients.

Authors:  L Brauner; G Kahlmeter; T Lindholm; O Simonsen
Journal:  J Antimicrob Chemother       Date:  1985-06       Impact factor: 5.790

View more
  1 in total

Review 1.  Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations.

Authors:  E Keller; P Reetze; P Schollmeyer
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.